
Chemical identity
Alogliptin Impurity C
CAS 1108731-49-2 · C20H23N5O3
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-05561 |
|---|---|
| PubChem CID | 138454990 |
| Name | Alogliptin Impurity C |
| CAS RN | 1108731-49-2 |
| Molecular formula | C20H23N5O3 |
| Molecular weight | 381.44 g/mol |
| IUPAC name | (R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)acetamide |
| InChIKey | DLPUDCLWEJZQGM-QGZVFWFLSA-N |
02Structure identifiers

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre. These statements are calculated from the published structure string.
| Defined stereocentres | 1 |
|---|---|
| Unassigned stereocentres | 0 |
| Ring count | 3 |
| Secondary amines | 0 |
| Tertiary amines | 1 |
| N-methyl amine sites | 0 |
| SMILES | CC(=O)N[C@@H]1CCCN(C1)C2=CC(=O)N(C(=O)N2CC3=CC=CC=C3C#N)C |
|---|---|
| InChI | Not listed |
| Formula from structure | C20H23N5O3 |
| Molecular weight from structure | 381.44 g/mol |
03Stereochemistry
The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.
Published same-connectivity configurations
2 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

![Two-dimensional chemical structure of N-[1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]acetamide](/structures/pubchem/155886930-300.png)
N-[1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]acetamide
CAS not listed
DLPUDCLWEJZQGM-UHFFFAOYSA-N
0 defined, 1 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
04India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NO EXACT MATCH FOUND | CAS 1108731-49-2 has no exact match in the reviewed published schedule. |
|---|---|---|
| SCOMET | NO EXACT REVIEWED CAS MATCH | CAS 1108731-49-2 has no exact match in the reviewed SCOMET list. |
| Review date | 2026-08-01 | Recheck the current official instruments for the material, concentration, activity and date in question. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · reviewed 2026-08-01
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · reviewed 2026-08-01
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · reviewed 2026-08-01
05Names and relationships
Associated parent compound
Alogliptin
View API and impurity familyOther names
- Alogliptin Impurity 15
- Alogliptin Impurity C
- 1108731-49-2
- N-Acetyl alogliptin
- Alogliptin metabolite m-II
- UNII-U93RK9Q9H6
- U93RK9Q9H6
- Acetamide, N-((3R)-1-(3-((2-cyanophenyl)methyl)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)-3-piperidinyl)-
- N-((3R)-1-(3-((2-Cyanophenyl)methyl)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)-3-piperidinyl)acetamide
- N-((3R)-1-(3-((2-Cyanophenyl)methyl)-1-methyl-2,6-dioxo-pyrimidin-4-yl)-3-piperidyl)acetamide
- N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]acetamide
- Alogliptin Impurity 3
06Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
07Sources
- S01PubChem compound record, CID 138454990
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
